FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Teniposide (Vumon) Injection
Status: Discontinuation
»Therapeutic Categories: Oncology; Pediatric

WG Critical Care (New )

Company Contact Information:
888-493-0861

Presentation Posting Date Related Information
50 mg/5 mL (10 mg/mL) vials (NDC 44567-0507-01) 06/28/2017 WG Critical Care will continue to take dropship orders until July 31st 2018. The line used to manufacture Teniposide Injection will not be in compliance with upcoming DSCSA regulations

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English